Cargando…

Dexmedetomidine and Ketamine as an Adjuvant to Levobupivacaine for Pediatric Caudal Analgesia: A Randomized, Controlled Study

BACKGROUND: Ketamine and dexmedetomidine as an adjuvant to caudal block are used in the pediatric population. AIMS: We aimed to compare the analgesic and safety profile of dexmedetomidine with ketamine for single-shot caudal block. SETTINGS AND DESIGN: This was a randomized controlled study conducte...

Descripción completa

Detalles Bibliográficos
Autores principales: Ram, Ganesh K., Dubey, Prakash K., Akhileshwar, P., Ranjan, Alok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819406/
https://www.ncbi.nlm.nih.gov/pubmed/33487825
http://dx.doi.org/10.4103/aer.AER_42_20
_version_ 1783639009795244032
author Ram, Ganesh K.
Dubey, Prakash K.
Akhileshwar, P.
Ranjan, Alok
author_facet Ram, Ganesh K.
Dubey, Prakash K.
Akhileshwar, P.
Ranjan, Alok
author_sort Ram, Ganesh K.
collection PubMed
description BACKGROUND: Ketamine and dexmedetomidine as an adjuvant to caudal block are used in the pediatric population. AIMS: We aimed to compare the analgesic and safety profile of dexmedetomidine with ketamine for single-shot caudal block. SETTINGS AND DESIGN: This was a randomized controlled study conducted in a tertiary care university hospital. MATERIALS AND METHODS: Ninety patients admitted for routine infraumbilical surgical procedures under general anesthesia were enrolled in this double-blind randomized study. Following caudal block under general anesthesia, patients were allocated to one of three groups; Group LS received 0.75 mL.kg (− 1) levobupivacaine 0.25% diluted in saline 0.9%, Group LK received 0.75 mL.kg (− 1) levobupivacaine 0.25% with ketamine 0.5 mg.kg (− 1), and Group LD received 0.75 mL.kg (− 1) levobupivacaine 0.25% with dexmedetomidine 1 μg.kg (− 1). Postoperative pain was assessed by the Face, Legs, Activity, Cry, and Consolability (FLACC) score, and the duration of analgesia (time from caudal block to time at which FLACC score 4 or more) was recorded. Hemodynamic parameters and oxygen saturation were also monitored. STATISTICAL ANALYSIS USED: Categorical data were analyzed by Chi-squire test and numerical continuous data were analyzed by Student's t-test for comparison between two groups. Mann–Whitney test was used to compare score. One-way analysis of variance was used to compare the means between three groups. RESULTS: The addition of dexmedetomidine and ketamine to levobupivacaine resulted in significant prolongation of postoperative analgesia duration (467 min and 385 min, respectively) compared with 0.25% levobupivacaine alone (276 min). No significant side effects requiring intervention were observed in any group. CONCLUSIONS: Dexmedetomidine as an adjuvant to levobupivacaine provides a longer duration of analgesia as compared to ketamine without any significant side effect.
format Online
Article
Text
id pubmed-7819406
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-78194062021-01-22 Dexmedetomidine and Ketamine as an Adjuvant to Levobupivacaine for Pediatric Caudal Analgesia: A Randomized, Controlled Study Ram, Ganesh K. Dubey, Prakash K. Akhileshwar, P. Ranjan, Alok Anesth Essays Res Original Article BACKGROUND: Ketamine and dexmedetomidine as an adjuvant to caudal block are used in the pediatric population. AIMS: We aimed to compare the analgesic and safety profile of dexmedetomidine with ketamine for single-shot caudal block. SETTINGS AND DESIGN: This was a randomized controlled study conducted in a tertiary care university hospital. MATERIALS AND METHODS: Ninety patients admitted for routine infraumbilical surgical procedures under general anesthesia were enrolled in this double-blind randomized study. Following caudal block under general anesthesia, patients were allocated to one of three groups; Group LS received 0.75 mL.kg (− 1) levobupivacaine 0.25% diluted in saline 0.9%, Group LK received 0.75 mL.kg (− 1) levobupivacaine 0.25% with ketamine 0.5 mg.kg (− 1), and Group LD received 0.75 mL.kg (− 1) levobupivacaine 0.25% with dexmedetomidine 1 μg.kg (− 1). Postoperative pain was assessed by the Face, Legs, Activity, Cry, and Consolability (FLACC) score, and the duration of analgesia (time from caudal block to time at which FLACC score 4 or more) was recorded. Hemodynamic parameters and oxygen saturation were also monitored. STATISTICAL ANALYSIS USED: Categorical data were analyzed by Chi-squire test and numerical continuous data were analyzed by Student's t-test for comparison between two groups. Mann–Whitney test was used to compare score. One-way analysis of variance was used to compare the means between three groups. RESULTS: The addition of dexmedetomidine and ketamine to levobupivacaine resulted in significant prolongation of postoperative analgesia duration (467 min and 385 min, respectively) compared with 0.25% levobupivacaine alone (276 min). No significant side effects requiring intervention were observed in any group. CONCLUSIONS: Dexmedetomidine as an adjuvant to levobupivacaine provides a longer duration of analgesia as compared to ketamine without any significant side effect. Wolters Kluwer - Medknow 2020 2020-10-12 /pmc/articles/PMC7819406/ /pubmed/33487825 http://dx.doi.org/10.4103/aer.AER_42_20 Text en Copyright: © 2020 Anesthesia: Essays and Researches http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Ram, Ganesh K.
Dubey, Prakash K.
Akhileshwar, P.
Ranjan, Alok
Dexmedetomidine and Ketamine as an Adjuvant to Levobupivacaine for Pediatric Caudal Analgesia: A Randomized, Controlled Study
title Dexmedetomidine and Ketamine as an Adjuvant to Levobupivacaine for Pediatric Caudal Analgesia: A Randomized, Controlled Study
title_full Dexmedetomidine and Ketamine as an Adjuvant to Levobupivacaine for Pediatric Caudal Analgesia: A Randomized, Controlled Study
title_fullStr Dexmedetomidine and Ketamine as an Adjuvant to Levobupivacaine for Pediatric Caudal Analgesia: A Randomized, Controlled Study
title_full_unstemmed Dexmedetomidine and Ketamine as an Adjuvant to Levobupivacaine for Pediatric Caudal Analgesia: A Randomized, Controlled Study
title_short Dexmedetomidine and Ketamine as an Adjuvant to Levobupivacaine for Pediatric Caudal Analgesia: A Randomized, Controlled Study
title_sort dexmedetomidine and ketamine as an adjuvant to levobupivacaine for pediatric caudal analgesia: a randomized, controlled study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819406/
https://www.ncbi.nlm.nih.gov/pubmed/33487825
http://dx.doi.org/10.4103/aer.AER_42_20
work_keys_str_mv AT ramganeshk dexmedetomidineandketamineasanadjuvanttolevobupivacaineforpediatriccaudalanalgesiaarandomizedcontrolledstudy
AT dubeyprakashk dexmedetomidineandketamineasanadjuvanttolevobupivacaineforpediatriccaudalanalgesiaarandomizedcontrolledstudy
AT akhileshwarp dexmedetomidineandketamineasanadjuvanttolevobupivacaineforpediatriccaudalanalgesiaarandomizedcontrolledstudy
AT ranjanalok dexmedetomidineandketamineasanadjuvanttolevobupivacaineforpediatriccaudalanalgesiaarandomizedcontrolledstudy